Cargando…
Correction: AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114437/ https://www.ncbi.nlm.nih.gov/pubmed/37072818 http://dx.doi.org/10.1186/s13046-023-02672-7 |
| _version_ | 1785028015344844800 |
|---|---|
| author | Gu, Chunyan Wang, Yajun Zhang, Lulin Qiao, Li Sun, Shanliang Shao, Miaomiao Tang, Xiaozhu Ding, Pinggang Tang, Chao Cao, Yuhao Zhou, Yanyan Guo, Mengjie Wei, Rongfang Li, Nianguang Xiao, Yibei Duan, Jinao Yang, Ye |
| author_facet | Gu, Chunyan Wang, Yajun Zhang, Lulin Qiao, Li Sun, Shanliang Shao, Miaomiao Tang, Xiaozhu Ding, Pinggang Tang, Chao Cao, Yuhao Zhou, Yanyan Guo, Mengjie Wei, Rongfang Li, Nianguang Xiao, Yibei Duan, Jinao Yang, Ye |
| author_sort | Gu, Chunyan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10114437 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101144372023-04-20 Correction: AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma Gu, Chunyan Wang, Yajun Zhang, Lulin Qiao, Li Sun, Shanliang Shao, Miaomiao Tang, Xiaozhu Ding, Pinggang Tang, Chao Cao, Yuhao Zhou, Yanyan Guo, Mengjie Wei, Rongfang Li, Nianguang Xiao, Yibei Duan, Jinao Yang, Ye J Exp Clin Cancer Res Correction BioMed Central 2023-04-19 /pmc/articles/PMC10114437/ /pubmed/37072818 http://dx.doi.org/10.1186/s13046-023-02672-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Gu, Chunyan Wang, Yajun Zhang, Lulin Qiao, Li Sun, Shanliang Shao, Miaomiao Tang, Xiaozhu Ding, Pinggang Tang, Chao Cao, Yuhao Zhou, Yanyan Guo, Mengjie Wei, Rongfang Li, Nianguang Xiao, Yibei Duan, Jinao Yang, Ye Correction: AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma |
| title | Correction: AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma |
| title_full | Correction: AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma |
| title_fullStr | Correction: AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma |
| title_full_unstemmed | Correction: AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma |
| title_short | Correction: AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma |
| title_sort | correction: ahsa1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114437/ https://www.ncbi.nlm.nih.gov/pubmed/37072818 http://dx.doi.org/10.1186/s13046-023-02672-7 |
| work_keys_str_mv | AT guchunyan correctionahsa1isapromisingtherapeutictargetforcellularproliferationandproteasomeinhibitorresistanceinmultiplemyeloma AT wangyajun correctionahsa1isapromisingtherapeutictargetforcellularproliferationandproteasomeinhibitorresistanceinmultiplemyeloma AT zhanglulin correctionahsa1isapromisingtherapeutictargetforcellularproliferationandproteasomeinhibitorresistanceinmultiplemyeloma AT qiaoli correctionahsa1isapromisingtherapeutictargetforcellularproliferationandproteasomeinhibitorresistanceinmultiplemyeloma AT sunshanliang correctionahsa1isapromisingtherapeutictargetforcellularproliferationandproteasomeinhibitorresistanceinmultiplemyeloma AT shaomiaomiao correctionahsa1isapromisingtherapeutictargetforcellularproliferationandproteasomeinhibitorresistanceinmultiplemyeloma AT tangxiaozhu correctionahsa1isapromisingtherapeutictargetforcellularproliferationandproteasomeinhibitorresistanceinmultiplemyeloma AT dingpinggang correctionahsa1isapromisingtherapeutictargetforcellularproliferationandproteasomeinhibitorresistanceinmultiplemyeloma AT tangchao correctionahsa1isapromisingtherapeutictargetforcellularproliferationandproteasomeinhibitorresistanceinmultiplemyeloma AT caoyuhao correctionahsa1isapromisingtherapeutictargetforcellularproliferationandproteasomeinhibitorresistanceinmultiplemyeloma AT zhouyanyan correctionahsa1isapromisingtherapeutictargetforcellularproliferationandproteasomeinhibitorresistanceinmultiplemyeloma AT guomengjie correctionahsa1isapromisingtherapeutictargetforcellularproliferationandproteasomeinhibitorresistanceinmultiplemyeloma AT weirongfang correctionahsa1isapromisingtherapeutictargetforcellularproliferationandproteasomeinhibitorresistanceinmultiplemyeloma AT linianguang correctionahsa1isapromisingtherapeutictargetforcellularproliferationandproteasomeinhibitorresistanceinmultiplemyeloma AT xiaoyibei correctionahsa1isapromisingtherapeutictargetforcellularproliferationandproteasomeinhibitorresistanceinmultiplemyeloma AT duanjinao correctionahsa1isapromisingtherapeutictargetforcellularproliferationandproteasomeinhibitorresistanceinmultiplemyeloma AT yangye correctionahsa1isapromisingtherapeutictargetforcellularproliferationandproteasomeinhibitorresistanceinmultiplemyeloma |